Skip to content

Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing non-psychosis mental health problems (NEON-O Trial)

The NEON-O Trial: a two-arm randomised controlled trial in which people with experience of non-psychosis mental health problems receive access to (arm 1) versus receive 1 year delayed access to (arm 2) recorded mental health recovery narratives delivered online, with quality of life as a primary outcome, and hope, empowerment, meaning in life and symptomatology as secondary outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN63197153
Enrollment
994
Registered
2020-01-09
Start date
2020-03-09
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health Mental and Behavioural Disorders Mental health

Interventions

Sponsors

Nottinghamshire Healthcare NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and above 2. Any gender 3. Experinece of mental health problem other than psychosis in the last five years 4. Experience of mental health-related distress in previous 6 months 5. Resident in England 6. Able to understand written and spoken English 7. Able to access or be supported to access the internet 8. Able to give online informed consent.

Exclusion criteria

Exclusion criteria: 1. If included in the NEON Trial (ISRCTN number: ISRCTN11152837)

Design outcomes

Primary

MeasureTime frame
Manchester Short Assessment (MANSA) of health-related quality of life, captured at 1 week, 12 weeks and 52 weeks (primary endpoint) after baseline.

Secondary

MeasureTime frame
Secondary outcome measures will be assessed at baseline, one week, 12 weeks and 52 weeks after baseline: 1. Hope will be assessed through the Herth Hope Index 2. Meaning in Life will be assessed through the Meaning in Life Questionnaire 3. Empowerment will be assessed through the Mental Health Confidence Scale 4. Symptomatology will be assessed through the CORE-10

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026